JPMorgan cut target for USA Compression Partners stock

JPMorgan cut its USA Compression Partners target from USD 29.00 to USD 28.00 on October 8, 2026, while keeping its Underweight rating, according to Business Insider. The move gives investors a concrete valuation marker as USA Compression Partners transitions its listing venue.

What does the target cut show?

The revised USD 28.00 target sits below the USD 29.50 average target cited in recent analyst coverage. MarketBeat reported on October 5, 2026 that Zacks Research raised its fourth-quarter 2027 earnings-per-share estimate from USD 0.29 to USD 0.30 and retained a Hold rating.

The latest reported operating picture was stronger than the target revision alone suggests. For the second quarter of 2026, revenue reached USD 342.15 million and diluted earnings per share were USD 0.31, compared with the USD 0.28 consensus estimate, according to MarketBeat on October 1, 2026.

Three recent milestones

On August 4, 2026, USA Compression Partners reported those second-quarter results, including USD 342.15 million in revenue and USD 45.65 million in net income. On September 3, 2026, the partnership approved the transfer of its common-unit listing from the New York Stock Exchange to the Texas Stock Exchange, with trading scheduled to begin on October 5, 2026, as Simply Wall St reported. On October 8, 2026, JPMorgan lowered its target from USD 29.00 to USD 28.00.

Next reporting date

TradingView lists November 3, 2026 as the next earnings date and gives a consensus estimate of USD 0.32 per share for the next quarter. The date places the next reported quarter at the center of the near-term debate, while the latest actual result remains the USD 0.31 diluted earnings per share delivered in the second quarter.

Market context: Market report S&P 500.

More news and analyses on USA Compression Partners stock